Grace Therapeutics (GRCE) Revenue (2020 - 2021)
Grace Therapeutics' (GRCE) quarterly Revenue came in at $115000.0 in Q1 2021, up 41.98% quarter-over-quarter from $81000.0 in Q4 2020.
Powered by 
Analysis
Grace Therapeutics (GRCE) Revenue (2020 - 2021) Analysis & Trends
Grace Therapeutics has disclosed Revenue across 2 years of filings, most recently posting $115000.0 for Q1 2021.
- In Q1 2021, Revenue changed N/A year-over-year to $115000.0; the TTM figure through Mar 2022 stood at $196000.0 (changed N/A YoY), while the FY2021 annual figure was $196000.0, changed N/A from the prior year.
- Revenue came in at $115000.0 for Q1 2021 at Grace Therapeutics, up from $81000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $115000.0 in Q1 2021 to a low of $81000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 15.03 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 13.48 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 1.67 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 783.30 Mn |
| 10 | Grace Therapeutics | 36.79 Mn | 36.79 Mn | - | - |